OR WAIT null SECS
December 18, 2023
The Multi-annual AI Workplan creates a strategy to maximize the benefits and manage the risks of artificial intelligence.
December 13, 2023
Sanofi has issued a statement expressing its disappointment with FTC’s decision to block an exclusive licensing agreement with Maze Therapeutics for a rare disease drug candidate.
Regulators in the European Union have published the first version a list of critical medicines in the EU to avoid potential shortages.
December 02, 2023
Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.
What does the 2024 VPAS mean for pharma?
December 01, 2023
Novo Nordisk will invest more than DKK 16 billion (US$2.3 billion) to expand its production facilities in Chartres, France.
November 27, 2023
Chris Spivey, editorial director for Pharmaceutical Technology, discusses messenger RNA (mRNA) advances with Guillaume Roelandts, Head of Products and Marketing, Quantoom Biosciences, at the 11th International mRNA Health Conference in Berlin, Germany.
November 24, 2023
The largest biotech hub is set to be built in Lithuania by Northway Group.
November 23, 2023
Hovione has acquired start-up company, ExtremoChem, expanding its technology platforms.
UK industry body, ABPI, has responded positively to the recent Autumn Statement.